Zai Lab Ltd at JPMorgan Healthcare Conference Transcript
We'll go ahead and get started. Yes, so we're getting started with this presentation. Welcome, everybody, to the Tuesday afternoon session of the 2020 JPMorgan Health Care Conference. My name is Anupam Rama. I am one of the senior biotech analyst here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team. Our next presenting company is Zai Lab, and presenting on behalf of the company, we have CEO, Samantha Du. Samantha?
Thank you, Anupam. And thank you, everyone, for coming. Can you hear me better? Should I yell? I will try. And I'd like to start the company presentation with the slide and about our recent approval. We recently have ZEJULA second line approved in Mainland China in December 27, 2019. This is actually a very major event because this really transformed Zai Lab from a development stage company into a fully commercial, fully integrated, not just -- not only in Taiwan, not in Hong Kong, Macao, but also in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
